High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria

Molecular Genetics and Metabolism

Volumn 98, Issue 4, 2009, Pages 344-348

  Profitlich, Laurie E ^a   Kirmse, Brian ^a   Wasserstein, Melissa P ^a   Diaz, George A ^a   Srivastava, Shubhika ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cobalamin metabolism; Congenital heart disease; Hyperhomocystinemia; Methylation defect; Non compaction

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COR PULMONALE; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE SEPTUM DEFECT; HOMOCYSTINURIA; HUMAN; INFANT; LUNG EMBOLISM; MALE; METHYLMALONIC ACIDURIA; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; NEWBORN; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; VITAMIN METABOLISM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FOLIC ACID; HEART DISEASES; HOMOCYSTINURIA; HUMANS; INFANT; INFANT, NEWBORN; MALE; METABOLISM, INBORN ERRORS; METHYLMALONIC ACID; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 70350622068     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.07.017     Document Type: Article

References (36)

1. Verkleij-Hagoort A., Bliek J., Sayed-Tabatabaei F., Ursem N., Steegers E., and Steegers-Theunissen R. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am. J. Med. Genet. A 143A 9 (2007) 952-960
2. Hobbs C.A., Cleves M.A., Melnyk S., Zhao W., and James S.J. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am. J. Clin. Nutr. 81 1 (2005) 147-153
3. Kapusta L., Haagmans M.L., Steegers E.A., Cuypers M.H., Blom H.J., and Eskes T.K. Congenital heart defects and maternal derangement of homocysteine metabolism. J. Pediatr. 135 6 (1999) 773-774
4. Homocysteine Studies Collaboration, Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis, JAMA 288(16) (2002) 2015-2022.
5. Naruszewicz M., Jankowska E.A., Zymlinski R., et al. Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance - pilot study. Atherosclerosis 194 2 (2007) 408-414
6. Nasir K., Tsai M., Rosen B.D., et al. Elevated homocysteine is associated with reduced regional left ventricular function: the multi-ethnic study of atherosclerosis. Circulation 115 2 (2007) 180-187
7. Vasan R.S., Beiser A., D'Agostino R.B., et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 289 10 (2003) 1251-1257
8. Tamura T., and Picciano M.F. Folate and human reproduction. Am. J. Clin. Nutr. 83 5 (2006) 993-1016
9. Lerner-Ellis J.P., Tirone J.C., Pawelek P.D., et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat. Genet. 38 1 (2006) 93-100
10. Kim J., Gherasim C., and Banerjee R. Decyanation of vitamin B12 by a trafficking chaperone. Proc. Natl. Acad. Sci. USA 105 38 (2008) 14551-14554
11. Rosenblatt D.S., Aspler A.L., Shevell M.I., Pletcher B.A., Fenton W.A., and Seashore M.R. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J. Inherit. Metab. Dis. 20 4 (1997) 528-538
12. Andersson H.C., Marble M., and Shapira E. Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet. Med. 1 4 (1999) 146-150
13. Heinemann M.K., Tomaske M., Trefz F.K., Bosk A., Baden W., and Ziemer G. Ventricular septal defect closure in a neonate with combined methylmalonic aciduria/homocystinuria. Ann. Thorac. Surg. 72 4 (2001) 1391-1392
14. Tomaske M., Bosk A., Heinemann M.K., et al. CblC/D defect combined with haemodynamically highly relevant VSD. J. Inherit. Metab. Dis. 24 4 (2001) 511-512
15. De Bie I., Nizard S.D., and Mitchell G.A. Fetal dilated cardiomyopathy: an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, cblC type. Prenat. Diagn. 29 3 (2009) 266-270
16. Longo D., Fariello G., Dionisi-Vici C., et al. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropediatrics 36 6 (2005) 366-372
17. Ogier de Baulny H., Gerard M., Saudubray J.M., and Zittoun J. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur. J. Pediatr. 157 Suppl. 2 (1998) S77-S83
18. Nugent A.W., Daubeney P.E., Chondros P., et al. The epidemiology of childhood cardiomyopathy in Australia. N. Engl. J. Med. 348 17 (2003) 1639-1646
19. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N. Engl. J. Med. 348 17 (2003) 1647-1655
20. Jenni R., Oechslin E., Schneider J., Attenhofer Jost C., and Kaufmann P.A. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86 6 (2001) 666-671
21. J. Finsterer, Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction, Pediatr. Cardiol. 2009.
22. P. Tanpaiboon, P.F. Callahan, I. Sloan, Noncompaction of the ventricular myocardium and hydrops fetalis in cobalamin C deficiency, Abstract Presentation at American Society for Human Genetics, 2006 (unpublished).
23. Hoffman J.I., and Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39 12 (2002) 1890-1900
24. Debray F.G., Boulanger Y., Khiat A., et al. Reduced brain choline in homocystinuria due to remethylation defects. Neurology 71 1 (2008) 44-49
25. Detich N., Hamm S., Just G., Knox J.D., and Szyf M. The methyl donor S-adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-adenosylmethionine. J. Biol. Chem. 278 23 (2003) 20812-20820
26. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 6 8 (2005) 597-610
27. Deng L., Elmore C.L., Lawrance A.K., Matthews R.G., and Rozen R. Methionine synthase reductase deficiency results in adverse reproductive outcomes and congenital heart defects in mice. Mol. Genet. Metab. 94 3 (2008) 336-342
28. Cerone R., Schiaffino M.C., Caruso U., Lupino S., and Gatti R. Minor facial anomalies in combined methylmalonic aciduria and homocystinuria due to a defect in cobalamin metabolism. J. Inherit. Metab. Dis. 22 3 (1999) 247-250
29. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327 26 (1992) 1832-1835
30. MRC vitamin study research group, Prevention of neural tube defects: results of the medical research council vitamin study, Lancet 338(8760) (1991) 131-137.
31. Hall J., and Solehdin F. Folic acid for the prevention of congenital anomalies. Eur. J. Pediatr. 157 6 (1998) 445-450
32. Verkleij-Hagoort A.C., Verlinde M., Ursem N.T., et al. Maternal hyperhomocysteinaemia is a risk factor for congenital heart disease. BJOG 113 12 (2006) 1412-1418
33. Malinow M.R., Rajkovic A., Duell P.B., Hess D.L., and Upson B.M. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. Am. J. Obstet. Gynecol. 178 2 (1998) 228-233
34. Swanson D.A., Liu M.L., Baker P.J., et al. Targeted disruption of the methionine synthase gene in mice. Mol. Cell. Biol. 21 4 (2001) 1058-1065
35. Chen P., Poddar R., Tipa E.V., et al. Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv. Enzyme Regul. 39 (1999) 93-109
36. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch. Intern. Med. 158 19 (1998) 2101-2106